Relative Bioavailability of a New Presentation of Apraglutide Versus the Reference Formulation
Clinical trial NCT06002555 · COMPLETED
Trial details
- NCT number
- NCT06002555
- Sponsor
- VectivBio AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-23
- Primary completion
- 2023-09-22
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.